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ABSTRACT 
Mycoplasma, the smallest self-replicating microorganism, is one of the most 
significant problems in the cell-culture field. It characterized by the absence of the cell 
wall, causing resistance to commonly used antibiotics in cell culture. The frequency of 
mycoplasma contamination has reached up to 35% worldwide, while the incidence found 
to be higher (42%) in Qatar. Numerous gene-expression studies have shown that 
mycoplasma dis-regulates thousands of genes on cultured cells causing unsafe biological 
products and erroneous experimental results. Therefore, it is critical to ensure that 
transcriptional changes due to mycoplasma are eliminated and gene-expression profile is 
restored to normal level after anti-mycoplasma treatment, to avoid biased results.  
For this purpose, first, we developed a survey to investigate the incidence of 
mycoplasma contamination in cell-cultures and most common methods used for 
mycoplasma detection and elimination in research laboratories in Qatar. Second, we used 
next-generation sequencing technology (illumina 4000 Hi-seq) to investigate the effect of 
mycoplasma on gene-expression profile of cultured cells and the ability of antibiotic 
treatment in reversing these changes.  
Results showed that number of dis-regulated genes in contaminated cells is 
increasing with the increase of sub-culturing. Affected genes were mainly related to cell 
death and survival and cell-to-cell signaling and interaction. Interestingly, genes dis-
regulation was not only due to mycoplasma contamination, antibiotic treatment also 
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contributed to the effect. Unlike the effect of mycoplasma, antibiotic treatment showed a 
shrinking pattern on the number of dis-regulated genes.  
Findings of this study concludes that mycoplasma contaminated-cells should 
not be further used or processed, specially for gene-expressions studies, due to the 
significantly dis-regulated genes as consequence of either mycoplasma or antibiotics 
effects.  
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CHAPTER 1: INTRODUCTION 
Cell-culture has become the most common biomedical model in biology and 
medical research (Zalai et al., 2015). Cell culture contamination with mycoplasma, 
the smallest self-replicating microorganism, is one of the most serious and significant 
problems in the cell-culture field (Laleh et al., 2011).  
Mycoplasma belongs to the Mollicutes class, with a unique feature of cell wall 
absence (Uphoff et al., 2014), making them resistant to most common antibiotics 
(streptomycin and penicillin) used in cell-culture (Miller et al., 2003; Uphoff et al., 
2011; Rottem et al., 2012). Because of their small size, mycoplasma are able to pass 
through the small pores (0.2 µm) of media sterilizing filters (Young et al., 2010). Cell 
contamination with mycoplasma cannot be easily detected under light microscopy 
and also they do not yield turbid growth (Nikfarjam et al., 2012). The three major 
sources of mycoplasma contamination in cell-culture are: 1) cross-contamination 
from infected cultures, 2) contaminated culture reagents (e.g. serum and trypsin), and 
3) laboratory personnel carrying certain type of mycoplasma, e.g. M. orale or M. 
fermentans (Hay et al., 1989). Several effective kits and methods have been 
established to detect and eliminate mycoplasma contamination like polymerase chain 
reaction (PCR) assay and antibiotics, respectively.  
The high incidence of mycoplasma contamination among primary and 
secondary eukaryotic cell lines (up to 87% of cell lines) represents a significant 
problem in research, diagnosis, therapy, and industrial production (Rawadi et al., 
1995). The first mycoplasma contamination incidence was reported in the 19th 
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century (Robinson et al., 1956), since then, the frequency of mycoplasma 
contamination in cell-culture has been extremely discussed in the literature 
(McGarrity et al., 1984; Hay et al., 1989; Nikfarjam et al., 2012. Previous reports 
showed high incidences of mycoplasma contamination reaching up to 35% globally, 
while in some countries like Japan and Argentina reported higher (65% and 80%) 
(Uphoff et al., 2012; Uphoff et al., 2014). 
The contamination of cell-culture by mycoplasma has diverse and 
comprehensive consequences, ranging from unsafe biological products, to erroneous 
experimental results (Miller et al., 2003). Due to the lack of amino acid biosynthesis 
genes, mycoplasma competes with its’ host cell nutrients and biosynthetic precursors 
(Razin et al., 2002), leading to DNA, RNA and protein synthesis alterations 
(McCormack et al., 1993). Using conventional gene qualification methods and 
microarray platforms, several gene-expression studies have shown that mycoplasma 
contamination significantly up regulates and down regulates thousands of genes like 
oncogenes, tumor suppressors, cytokines and growth factors (Miller et al., 2003; 
Zhang et al., 2006). However, none of these studies investigated the reversibility of 
these transcriptional changes after antibiotic treatment of contaminated cells.  
 
1.1 HYPOTHESIS 
Antibiotic treatment of mycoplasma contamination in cell-culture will not 
eliminate transcriptional changes caused by the mycoplasma, neither restore cell’s 
gene-expression profile to normal expression. 
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1.2 SIGNIFICANCE OF THE PROBLEM 
In gene-expression studies, it is critical to ensure that transcriptional changes 
are originated from experimental condition, but not due to other artifacts or 
contaminants. Therefor, it is important to eliminate mycoplasma contamination in 
cell-culture and to ensure that gene-expression profile is restored to normal level after 
antibiotic treatment, to avoid biased results. High throughput RNA-sequencing 
platform will be used, to investigate the transcriptional changes caused by 
mycoplasma contamination in cell-culture and assess the reversibility of these 
transcriptional changes after antibiotic treatment of contaminated cells. All the work 
will be guided by a survey developed to investigate the incidence of mycoplasma 
contamination in cell-cultures and the techniques frequently used for the detection 
and elimination of mycoplasma in research laboratories in Qatar. 
 
1.3 RESEARCH AIMS AND OBJECTIVES 
The aim of this study is to investigate the validity of using mycoplasma-
contaminated cell-culture post antibiotic treatment in gene-expression studies. 
  
OBJECTIVES: 
1- Develop a survey to investigate the incidence of mycoplasma contamination in 
cell-cultures and the techniques frequently used for the detection and 
elimination of mycoplasma in research laboratories in Qatar. 
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2- Investigate the effect of mycoplasma in cell morphology and gene-expression 
profile. 
3- Assess the ability of anti-mycoplasma treatment (antibiotics) in reversing 
gene-expression and morphological changes caused by mycoplasma. 
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CHAPTER 2: REVIEW OF THE LITERATURE 
2.1 MYCOPLASMA 
To explore the altered appearance of plant cell cytoplasm, resulting from 
fungus like microorganisms infiltration, Albert Bernhard Frank was the first to use 
the term mycoplasma in 1889 (Mehrotra et al., 2015). Mycoplasma is the derivative 
of Greek µυκής, mykes (fungus) and πλάσµα, plasma (formed). Since the work of 
Edward and Freundt in 1950s the original term has been extensively used although it 
was substituted by Pleuropneumonia-like organisms (PPLO) (Edward et al., 1936). 
Due to the absence of cell wall around the plasma membrane, mycoplasma is 
grouped to the genus of bacteria on which antibiotics do not exert prominent effect 
(such as penicillin). The inactivity of antibiotics is attributed to the lack of cell wall, 
which is the target of these antibiotics (such as beta-lactam antibiotics). Majority of 
mycoplasma including M. pneumonia have been found to be human pathogens, 
although, these can be parasitic in nature as well (Nocard et al., 1990).  
The first mycoplasma species found in human, now is called M. hominis, was 
isolated by Edsall and Dienes from a gland abscess (Tully et al., 1996; Waites et al., 
2006). This discovery was in 1956 in cell cultures, after the finding of mycoplasma 
growth in negative control in cell cultures, (Robinson et al., 1956). 
Cell cultures, animals and human have been found to be the host of 
mycoplasma, where it can live as pathogens or commensally (the human is known to 
be used as primary host by approximately 16 - 20 species). Mycoplasma exhibit tissue 
host specificities and it has the ability to survive for prolonged period of time, and 
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increase in number after entry into cell. Their ability to avoid the detection by host 
immune system is attributed to the development of mimicry against host antigens as 
observed by mycoplasma over time (Razin et al., 1998, Rottem et al., 2003). 
 
2.2 TAXONOMY OF MYCOPLASMA 
Humans are known to be use as primary host by at least 16 out of more than 180 
species of mycoplasma discovered to date. They form one of the eight sub-divisions 
(or genera) that constitute the Mollicutes class. 
The close relationship of mycoplasma to Lactobacillus, Bacillus and Gram-
positive Clostridia has been clearly demonstrated by phylogenetic studies involving 
the sequence analysis of 16S mRNA. Because of phenotypic properties and sequence 
similarities, mycoplasma, however, have been reclassified into three groups 
spiroplasma, pneumonia and homini (Figure 2.1) (Weisburg et al., 1989; Drexler et 
al., 2000). 
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Figure 2.1. Phylogenetic tree of mycoplasmas based on 16S rRNA sequences. Showing 
more than 180 species of mycoplasma discovered to date, which are belong to Mollicutes class, 
classified into three main groups: spiroplasma (II), pneumonia (III) and homini (IV) (Razin et al., 
2006) 
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2.3 BIOLOGY OF MYCOPLASMA 
Generally, to date, mycoplasmas are the smallest self-replicating organisms and 
found to be between 0.1 to 0.8 µm (Razin et al., 1978; Drexler et al., 2000). They 
have been discovered to be pleomorphic and are able to demonstrate a variety of 
shapes like pear, flask, pill and filamentous amongst others (Kim et al., 1966; Razin 
et al., 1998). Additionally, they are characterized by absence of the cell wall, instead 
they are surrounded by 3 layers of lipoprotein membrane (Figure 2.2), which make 
them immune against the effect of antibiotics that target cell wall synthesis in order to 
kill the cell (Razin et al., 1998; Rottem et al., 2003). This may be because they lack 
many of the enzymatic pathways such as wall production pathway, a functional 
tricarboxylic acid cycle as well as a cytochrome mediated electron transport system 
(Dybvig et al., 1996; Drexler et al., 2000). 
 
 
 
 
Figure 2.2. Cell structure of mycoplasma. Showing the main components of mycoplasma and the 
three layers of lipoprotein membranes that replacing the cell wall  (www.invivogen.com) 
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Mycoplasma have been known to form colonies after 3 to 5 days on a solid agar 
with a characteristic ‘fried egg’ appearance (Figure 2.3) with a diameter of up to 400 
µm, while in other cases they have been observed to grow slowly and not be 
recognizable for up to 3 weeks or more (Drexler et al., 2002). 
 
 
 
 
Figure 2.3. Typical mycoplasma colonies on agar. Showing the classic ‘fried egg’ appearance of 
most of mycoplasma growth under the microscope, 3 to 5 days (Young et al., 2010) 
 
 
Owning a double strand DNA, investigations showed that mycoplasma uses a 
binary fusion method to divide. It is also noted that the division of cytoplasm and the 
replication of mycoplasma genome are following an asynchronous rather than 
synchronous replication. Which explain the phenomena of filament formation and 
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cocci chains transformation of mycoplasma during division process (until division is 
complete) (Razin et al., 1998; Drexler et al., 2000). However, they have a relatively 
long lag phase with a generation time of between 1 to 9 hours (Drexler et al., 2000). 
The genome of mycoplasma has been found to range from 580 kb to 2.22 kb 
(M. genitalium and Spiroplasma respectively), with GC content up to 33 mol%. 
Unlike other bacteria, the genome size of mycoplasma considered being very small, it 
consists of around 500 genes (one-fifth size of bacterial genome) (Dybvig et al., 
1996; Razin et al., 1998; Drexler et al., 2000; Rottem et al., 2003). Is has also been 
found to possess inefficient energy yielding pathways (Dybvig et al., 1996; Drexler et 
al., 2000). 
Mycoplasma is characterized as either non-fermentative or fermentative on 
the basis of their potential to produce ATP. In non-fermentative mycoplasma, ATP is 
produced by arginine hydrolysis using arginine dihydrolase pathway, whereas the 
carbohydrate fermentation by using glycolytic pathway is responsible for ATP 
production in fermentative Mycoplasma. However, both metabolic pathways have 
been observed to be involved in ATP production in some mycoplasma such as M. 
fermentans. On the basis of enzymatic ATP production found in both groups of 
mycoplasma (non-fermentative and fermentative), an alternative pathway for ATP 
production was suggested as a consequence of above discoveries and observations 
(Razin et al., 1978 & 1998; Drexler et al., 2000). 
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2.4 MYCOPLASMA IN CELL CULTURES 
Remaining virtually undetectable under a conventional microscopy, 
mycoplasma has been observed to be very easily contaminating cell-cultures under 
regular laboratory conditions. It is able to present itself without causing any visible 
effects and can therefore remain relatively undetected. Due to its plasticity it is able to 
pass through some microbiological filters that measure 0.22 µm or less (Drexler et 
al., 2000). In addition, it is able to show resistance to most common cell-culture 
antibiotics due to the fact that it is Gram-negative and lack of the cell wall, as 
mentioned above, antibiotics typically tend to target for cell wall destruction (Drexler 
et al., 2000; Uphoff et al., 2005). 
Due to mycoplasma persistent nature and resistance to dehydration, 
contaminated cell lines as well as reagents, laboratory equipment and individuals can 
very easily provide a source of mycoplasma contamination (McGarrity et al., 1985; 
Tully et al., 1996; Drexler et al., 2000 & 2002).  
Typically, mycoplasma can grow very well in cell cultures, but mycoplasma 
infection is very much dependent on the dosage and concentration and type of cells 
involved. Given the right conditions, within three to five days, individual 
mycoplasma cell has been observed to grow to million CFU/ml (Colony Forming 
Unit per milliliter) in contaminated cell-culture with a titers of millions to hundred 
millions CFU/ml. Under the microscope, it has been observed that around 100 to 
1000 mycoplasmas will attach themselves to each host cell whenever there is a heavy 
or concentrated infections (Drexler et al., 2000). 
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2.5 INCIDENCE OF MYCOPLASMA CONTAMINATION IN CELL CULTURES 
The frequency of in vitro mycoplasma contaminations can vary worldwide 
depending on the detection methods used, geography, number and concentration of 
cell cultures examined (McGarrity et al., 1985; Tully et al., 1996). In comparison to 
the contamination rates of 35% and 15% in animal and human cell lines, primary cell 
cultures and their sub-cultivated passages are less frequently contaminated with 
reported evidences of only 1% and 5%, respectively (Table 2.1) (Drexler et al., 2002). 
In the beginning of 1990s, over twenty thousands cell cultures tested by United States 
Food and Drug Administration (USFDA), 15% of cells were found to be mycoplasma 
contaminated (Rottem et al., 1993). In addition, 70% and 28% cell lines were 
mycoplasma positive in Argentina and Germany, respectively (Coronato et al., 1990; 
Drexler et al., 2002). Recently, RNA-sequencing data showed contamination rate of 
11% and 7% (Olarerin-George and Hogenesch, 2014; Langdon, 2014).	  	  	  
Table 2.1. Incidence of mycoplasma contamination (Drexler and Uphoff, 2002) 
 
Cell type Incidence 
Continuous human or animal cell lines 15–35% 
Early passage cell cultures 5% 
Primary cell cultures 1% 
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Due to the use of contaminated serum, animal mycoplasma species such as M. 
arginine and M. hyorhinis were thought to be the most commonly found species of 
mycoplasma in cell cultures (McGarrity et al., 1985). However, current studies 
indicates that M. orale (a species that prefers humans as host) is the most commonly 
found species with a frequency rate of 20% to 40% (possibly as a result of 
contamination from individuals), followed by M. hyorhinis (10% to 40%), M. 
arginine (30%) and M. fermentans / M. hominis (10% to 20%) (Table 2.2) (Drexler et 
al., 2002). However, the incidence of multiple infections, that involve two 
mycoplasmas species or more, can be as low as 7% or higher up to 60% (Uphoff et 
al., 2002; Timenestsky et al., 2006). 
 
 
Table 2.2. Most common Mycoplasma species (Drexler and Uphoff, 2002) 
 
 
  
 
 
Mycoplasma species Source Incidence 
M. orale Human 20-40% 
M. hyorhinis Swine 10-40% 
M. arginini Bovine 20-30% 
M. fermentans Human 10-20% 
M. hominis Human 10-20% 
A. laidlawii Bovine 5-20% 
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2.6 EFFECTS OF MYCOPLASMA CONTAMINATION 
It has been observed that under laboratory conditions, mycoplasma can affect 
various cell parameters such as growth and proliferation, morphology, metabolism, 
genome and antigenicity of contaminated cells (McGarity et al., 1984 & 1985; 
Drexler et al., 2000 & 2002). 
Effect of mycoplasma is very much dependent on the particular species of 
mycoplasma, cell type to be infected, conditions of culture, intensity and duration of 
infection (Drexler et al., 2002). 
With regard to growth, morphology and metabolism cytopathic effects of 
mycoplasma on cells have been observed as a result of cell component consumption 
by mycoplasma. Mycoplasma consumes cell supplements, nutrients and cell 
metabolism components e.g. nucleic acid precursors, amino acids, vitamins, 
cholesterol and lipids. These compounds are normally used up very rapidly due to the 
fact that they have a low metabolic rate, an inefficient energy gain and because of a 
possible high number of mycoplasma present in the cell culture. Furthermore, the 
production of hydrogen peroxide (H2O2), low pH environment and the exhaustion of 
arginine plus other nutrients have also been noted and these have been found to 
induce increased granularity, cytotoxicity and lysis resulting in cell death (McGarity 
et al., 1985; Drexler et al., 2000). Mycoplasma also affect RNA / DNA synthesis, 
change the proteins level and directly affect cell metabolism resulting in cell 
degeneration that shows pyknotic nuclei, marginated chromatin and segregated 
(Stanbridge et al., 1971; Drexler et al., 2000 & 2002). 
	   15	  
In addition, mycoplasma has been observed to affect the proliferation and 
growth rate of contaminated cells, causing irregular and arrested growth patterns with 
other abnormalities such as rounded degenerated cells and detachment of monolayers. 
However, the introduction of certain nutrients to culture could reverse some effects 
while others remain irreversible (Drexler et al., 2000). 
With regard to effects on genome, mycoplasma have the ability to degrade host 
cell DNA (Paddenberg et al., 1998) and dis-regulate hundreds of host genes, mainly 
effecting genes associated with immune responses, cell-cycle regulation and signal 
transduction pathways (Hopfe et al., 2013). Mycoplasma infections have been 
observed to cause a reduction of the number of chromosomes present, and cause 
variations in the appearance of new chromosomes. But the main effects of 
mycoplasma on the genome are chromosomal aberrations such as chromatid breaks, 
achromatic gaps, rearrangements and translocations, dysenteric and pulverization 
(Barile et al., 1979, McGarrity et al., 1985, Drexler et al., 2000). 
Regarding the effects on antigenicity, in vitro, mycoplasma can affect 
hematopoietic cells by stimulating, or conversely, inhibiting their activation, 
propagation and differentiation by enhancing the immunoglobulin secretion of B-cells 
and the induction of cytokines and growth factors (McGarity et al., 1985; Razin et al., 
1998; Drexler et al., 2000). All these effects are because of the way that mycoplasma 
interacts with cells and cause changes in the composition of the cell membrane, which 
subsequently affects the expression of surface antigens and receptors (Drexler et al., 
2000). This can also directly influence viruses to propagate in the cultured cell. While 
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the non-fermentative mycoplasma, has the ability of arginine depletion, can 
negatively effect arginine dependent viruses propagation (such as Herpes simplex, 
adeno-viruses and vaccinia) (McGarrity et al., 1985; Drexler et al., 2000). 
 
2.7 DETECTION OF MYCOPLASMA IN CELL CULTURES 
The extensive use of cell cultures in medical research and in the manufacturing 
of biological products, all cells should be screened for the presence of mycoplasma 
before being used. This is due to the direct effects of mycoplasma on several 
biological cell parameters (as discussed above), which can ultimately cause 
misleading experimental results and contaminate intended biological products. So far, 
several techniques have been developed for the detection of mycoplasma in cell 
cultures (Table 2.3) (Drexler et al., 2000).  
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Table 2.3. Selected Methods for Mycoplasma Detection (Drexler et al., 2000) 
 
Microbiological culture • Growth in liquid medium or Broth 
• Formation of typical small colonies on agar (Figure 2.3) 
Electron microscopy • Transmission/Scanning electron microscopy (Figure 2.4 and 2.5) 
Biochemical assays • Detection of adenosine phosphorylase activity (6-MPDR assay) 
• Enzymatic conversion of ADP to ATP detected by luciferase 
• Chromatographic detection of conversion of radioactively labeled uridine to 
uracil by Mycoplasmal uridine phosphorylase 
Immunological assays • Immunofluorescence 
• Enzyme linked immunosorbent assay (ELISA) 
Molecular biological 
assays 
• Liquid hybridization assay 
• Autoradiography (dot-blot) with Mycoplasma specific probes 
• Polymerase chain reaction (PCR) (Figure 2.6) and reverse transcription PCR 
• PCR-ELISA 
• Species-/genus–specific PCR primers or universal PCR primers 
• Gradient electrophoresis separation of labeled RNA 
Microscopic detection 
assays 
• Direct DNA fluorescent staining (DAPI, Hoechst 33258) (Figure 2.7) 
• Indirect DNA fluorescent staining with indicator cell line 
• Fluorescent in situ hybridization 
Histological staining • Histochemical stains and light microscopy 
Protein analysis  
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Figure 2.4. Transmission electron microscopy of melanoma cell culture infected by M. hyorhinis. 
Showing flask shaped mycoplasma adhering to the surface of melanoma cells as an initial step of 
colonization (indicated by arrows) (Rottem et al., 2012) 
 
 
The above table is not exhaustive, and the methods employed are dependent 
upon the procedures used for the particular objective. The mycoplasmologists from 
The International Organization for Mycoplasmology (IOM)	   have developed two 
methods for the recognition of mycoplasma in cell-cultures – ‘direct’ and ‘indirect’. 
Generally, the direct method refers to the standard approach of microbiological 
colony growing on agar which is aimed at detecting viable mycoplasma cells, while 
the indirect approach refers to processes and methods used to measure the gene 
products of mycoplasma such as proteins or enzymes, or to measure the metabolic 
and other properties of the affected cells (Drexler et al., 2000). 
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Figure 2.5. Scanning electron micrographs (SEM) of HGE-3 cells with mycoplasma 
contamination. The yellow box showing a magnification of individual mycoplasmas adhering into the 
surface of the HEG-3 cells (highlighted by arrows) (Falagan et al., 2015) 
 
 
 
 
Figure 2.6. Mycoplasma detection using PCR detection method.  The PCR includes amplification 
with specific primer set of the highly conserved 16S rRNA coding region in the mycoplasma genome. 
PCR product loaded into 2% agarose gel. Negative samples represent a single 500bp band while 
positive samples represent either single 250bp or double 500bp and 250bp bands. (SIGMA, LookOut 
Mycoplasma PCR detection protocol) 
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Figure 2.7. Mycoplasma contaminated cell culture stained with a fluorescent DNA stain. 
Mycoplasma appears on the cell surface as a filamentous or particulate pattern of bright fluorescence 
indicating mycoplasma DNA (Rottem et al., 2012) 
 
 
However, many of these methods are exorbitant to use, because they are 
complex, difficult to implement and interpret, expensive and time consuming. Thus, 
there is a critical need of sensitive, specific, rapid, cost effective, efficient and easy to 
use and interpret methods to detect presence of mycoplasma (Uphoff et al., 1992 & 
2002; Drexler et al., 2000 & 2002).  
Knowing the variability of Mycoplasma detection methods, single detection 
method should not be relied upon and any results obtained should be confirmed by a 
second and separate method. However, it could be possible to use the same method, 
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with identical resource, in disperse locations, in order to check for the concordance of 
the results.  
Currently, cell culture in broth and/or agar media such as Friis, PH-Hayflick, 
SP4 and DM-1 (Hayflick et al., 1965; Uphoff et al., 1992; Tully et al., 1996) and 
PCR assays based on the 16S RNA sequence regions and 16S-23S intragenic regions 
of mycoplasma species have shown to be very reliable to detect mycoplasma (Drexler 
et al., 2002; Razin et al., 1994; Rawadi et al., 1995; Harasawa et al., 1999; Uphoff et 
al., 2005; Timenetsky et al., 2006).  
 
2.8 ELIMINATION AND ERADICATION OF MYCOPLASMA IN CELL CULTURES 
According to the International Organization for Standardization (ISO), all the 
cell cultures used either for studying the consequences of drugs and toxic complexes, 
mutagenesis and carcinogenesis, drug inspection and progress, and manufacturing of 
biological compounds (e.g., vaccines, therapeutic proteins) must be mycoplasma-free. 
Additionally, prestigious scientific journals such as Nature Biotechnology, and others, 
are also requires an author's statement of the use of mycoplasma-free and certified 
cells (UKCCCR, 2000; Nature Biotechnology Editorial, 2013). However, recent 
studies published in Nature, Cell, Genome Research, PNAS, and Genes and 
Development (top peer-reviewed journals) have reported high numbers of 
mycoplasma contamination (Olarerin George and Hogenesch, 2015) 
It has been well established that in cell-culture, mycoplasma-free cell should be 
stock for routine laboratory work (McGarrity et al., 1985; Uphoff et al., 1992 & 
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2005). But where mycoplasma free cells are not freely available, or the cells are 
irreplaceable or valuable, then mycoplasma should be eradicate. 
So far several techniques such as antibiotic treatment, co-cultivation of infected 
cells with macrophages, exposure to selectively toxic detergents, in vivo passage of 
constant cell lines through nude mice, induction of chromosomal damage using 
visible light and 5-bromouracile and use of anti-mycoplasma sera have been 
developed (Schmidt et al., 1984, McGarrity et al., 1985; Schmitt et al., 1988; Drexler 
et al., 2000 & 2002; Uphoff et al., 2005). However, these techniques can be 
changeable, ineffectual, impractical, cannot be useful to every condition, time 
consuming, expensive and can cause changes to the characteristics and properties of 
the cells (McGarrity et al., 1985; Schmitt et al., 1988; Uphoff et al., 1992; Drexler et 
al., 2002). 
The antibiotics remain the most dependable and effective approach for treating 
cells and cell-cultures infected with mycoplasma (Schmidt et al., 1984). Amongst 
others, various Antibiotics are available for example; tetracycline, kanamycin, 
linomycin, erythromycin and tylosine which were used in various combinations and 
procedures for the elimination plus eradication of Mycoplasma. However, that 
resistance to several of the Antibiotics has been observed. Tiamutin and Minocyclin 
Antibiotics were noticed to be very efficient when used continuously for a number of 
weeks and that they did not produce any unwanted effects. It was then possible to 
clone the cells in order to produce an effective Mycoplasma free cell line (Schmidt et 
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al., 1984). Optimal results can also be achieved with the use of Ciprofloxacin and 
other Quinolones Antibiotics (Schmitt et al., 1988, Uphoff et al., 1992).  
Tetracyclines, macrolides and quinolones were found to be the highest effectual 
Antibiotics against Mycoplasma. However, if applied in low concentrations they will 
have little or no effect but the possibility of the Mycoplasma cells and cell cultures 
developing a resistance to them will remain low. According to Uphoff, the most 
effective and therefore the Antibiotics of choice are Tiamutin, Minocycline, 
Quinolones and Mycroplasmal Removal Agent (MRA). Macrolide Tiamulin (BM-
cyclin 1) and Tetracycline Minocycline (BM-cyclin 2) which bind to the 30S and the 
50S ribosomal units, found to be the reason of inhibition of protein synthesis, while 
the inhibition of bacterial DNA replication (gyrase) is caused by quinolones and 
MRA (Uphoff et al., 2005). 
It has been reported that 4 weeks of time is essential for antibiotic treatment to 
be effective and to declare the mycoplasma free cells, treated cells should be monitor 
up to 6 weeks using the sensitive detection methods (Schmidt et al., 1984, Schmitt et 
al., 1988, Uphoff et al., 1992 & 2005; Drexler et al., 2000 & 2002).  
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CHAPTER 3. MATERIALS AND METHODS 
3.1 MATERIALS AND REAGENTS 
 
Table 3.1-5 contains a list of all the materials and their resources used in the research. 
 
 
Table 3.1. LIST OF REAGENTS 
 
Item Company Part Number 
Agencourt AMPure XP Beckman Coulter Genomics A63881 
Antibiotic Antimycotic 
Solution 100ml SIGMA A5955-100ML 
Bionexus, Inc All Purpose Hi-
Lo DNA Marker Bionexus BN2050 
Chloroform: Isoamyl Alcohol 
24:1 AMRESCO X205-950ml 
Dimethyl Sulphoxide DMSO SIGMA D2438 
Disruptor beads Electron Microscopy Sciences 72408-05 
DMEM, high glucose, pyruvate Gibco 11995073 
Fetal Bovine Serum SIGMA F7524-500ml 
Gel Loading Dye Blue (6X) BioLabs B7021S 
PBS - Phosphate-Buffered 
Saline pH 7.4 Gibco 10010049 
RNaseZap Ambion 9782 
TC10 Trypan Blue Dye BIO-RAD 1450013 
Trizol Reagent RNA thermofisher 15596-026 
Trypsin (.25%) EDTA (.1%) 
500ml SIGMA 59429C-500ML 
VECTASHIELD®Mounting 
Medium with DAPI VECTOR Laboratories H-1200 
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Table 3.2. LIST OF KITS 
 
Item Company Part Number 
Agilent DNA 1000 Kit Agilent 5067-1504 
Agilent RNA 6000 Nano Kit Agilent 5067-1511 
BM-Cyclin Roche 10799050001 
HiSeq 3000/4000 PE Cluster Kit 
cBot (Box 1 of 2) 
illumina 15067099 
HiSeq 3000/4000 PE Cluster Kit 
cBot (Box 2 of 2) 
illumina 15067100 
HiSeq 3000/4000 SBS Kit 300 cycles 
(Box 1 of 2) 
illumina 15067104 
HiSeq 3000/4000 SBS Kit 300 cycles 
(Box 2 of 2) 
illumina 15067105 
LOOKOUT MYCOPLASMA PCR 
DETECTION KIT, LO 
SIGMA MP0035-1KT 
Nextflex Rapid RNA-Sek kit Bioo Scientific 5138-02 
NEXTflex™ RNA-Seq Barcodes Bioo Scientific 512912 
TruSeq Multiplex Sequencing 
Primer 
illumina 15017557 
JUMPSTART TAQ DNA 
POLYMERASE, JUMPSTART 
SIGMA D9307-50UN 
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Table 3.3. LIST OF INSTRUMENTS 
 
Item Company Part Number 
2100 Bioanalyzer Laptop 
Bundle Agilent G2943CA 
cBot illumina 6001192 
Confocal LSM 710 Carl ZEIZZ LSM 710 
FlashGel System Lonza 57067 
HiSeq 4000 Systems illumina sy-401-4001 
TC20 automated cell counter BIO-RAD 1450102 
 
 
Table 3.4. LIST OF LAB SUPPLIES 
 
Item Company Part Number 
Cell culture flask vented, surface 75 cm2 BD FALCON 353136 
Fisherbrand™ Disposable Borosilicate Glass Pasteur Pipets FisherBrand 13-678-20D 
FlashGel DNA Cassette 2.2% Agarose Lonza 57031 
Glass Bottom Microwell Dishes MatTek P35GC-0-10-C 
Nalgene CN Filter Units 500 mL Thermo Scientific 450-0020 
NALGENE Cryo 1°C freezing container NALGENE 5100-0001 
Serological Pipette 10ml - 1/10ml, individual wrap case of 200 BD FALCON 357551 
TC10 Counting Slides, box of 30 slides BIO-RAD 1450011 
TipOne® 101-1000 µl Filter Pipet Tips in Sterilized Racks, 10 
racks of 96 tips (960 tips) 
USA SCIENTIFIC 1126-7810 
TipOne®1-200 µl Natural Pipet Tips in Sterilized Racks, 10 
racks of 96 tips (960 tips) 
USA SCIENTIFIC 1111-0810 
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Table 3.5. LIST OF LICENSED SOFTWARE 
 
Item Company 
Ingenuity Pathway Analysis IPA QIAGEN 
PartekFlow Partek 
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3.2 STUDY DESIGN  
 
Figure 3.1. Cell-culture work’s study design. Early passages represent 4 passages 
(P4) and late passages represent 8 passages (P8). The workflow illustrates time point 
of cell harvesting, gene-expression analysis and pathway analysis.  
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3.3 METHODS 
3.3.1 ETHICAL APPROVAL  
This study dose not includes any human/tissue samples and their related data, 
ethical approval is not required. 
 
3.3.2 SAFETY  
 
For safety purposes, laboratory safety registration documentation was obtained 
from Environmental Health and Safety department at WCM-Q (Appendix A). The 
documentation is certifying that the Genomics Core lab is safe to operate and the all 
research team members have received the required training to conduct research safely 
and in accordance with applicable institutional laws, regulations, and best practices. 
 
3.3.3 SURVEY 
To investigate the incidence of mycoplasma contamination in cell cultures and 
the most common methods used for mycoplasma detection and elimination in 
research laboratories in Qatar, a survey was developed using a web base Survey 
(https://www.surveymonkey.com). The survey included 9 multiple-choice questions 
(Appendix B).   A link of the survey was sent to several research institutes in Qatar 
(https://www.surveymonkey.com/r/DV9BP69) and collected data were analyzed 
using SurveyMonkey web tools. The survey is anonymous, confidential and dose not 
implicates any risks to participant’s work. 
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3.3.4 CELL CULTURE 
SKOV3 human ovarian adenocarcinoma cell line (ATCC® HTB77) was 
purchased from (ATCC, USA). Cells handling and sub-culturing were performed 
according to manufacturer's protocol. Briefly, SKOV3 cells were maintained in high-
glucose, Dulbecco’s Modified Eagle Medium (DMEM), supplemented with 10% 
Fetal Bovine Serum (SIGMA®, USA) and 1% antibiotic antimitotic solution 
(SIGMA, USA). Prepared medium were filtered with Nalgene® vacuum filtration 
system. Cells were grown in a 75 cm2 culture flask at 37°C in 5% CO2. Medium was 
changed every 2–3 days. Upon achieving 70–80% confluence, cell were passaged 
with sub-cultivation ratio of 1:3. 
 
3.3.5 CONTAMINATING CELL WITH MYCOPLASMA 
SKOV3 cells were infected with mycoplasma using 10 µl of mycoplasma-
contaminated medium (supernatant). This supernatant was obtained from the same, 
previously contaminated, cell line (SKOV3). The presence of mycoplasma in the 
supernatant was confirmed using Lookout® mycoplasma polymerase chain reaction 
(PCR) detection kit (SIGMA, USA). 
 
3.3.6 CELL COUNT 
Prior to each sub-culturing, number of growing cells was counted using TC10 
Trypan blue dye/ TC20 automated cell counter (Bio-Rad).  
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3.3.7 DETECTION OF MYCOPLASMA 
To determine mycoplasma contamination before harvesting and each passage, 
PCR assay and DAPI staining were used. 
 Lookout mycoplasma PCR detection kit was used according to the 
manufacturer's instructions (SIGMA, USA). The kit utilizes PCR technology using 
primers that are highly specific and conserved 16S rRNA coding region in 
mycoplasma genome. Before each sub-culturing of SKOV3 cells, 100 µl of 
supernatant were transferred to new tube, heated at 95°C for 5 minutes and incubated 
with PCR mix for 40 cycles (94°C for 30 seconds/ 55°C for 30 seconds / 72°C for 40 
seconds) . A negative control (nuclease free water) and positive control (provided 
with the kit) were included in each reaction. PCR products were visualized on Fast 
Electrophoresis Lonza's FlashGel™ System (Lonza, USA) along with 100 bp DNA 
Marker (Bionexus, USA).  
DAPI, (4',6-diamidino-2-phenylindole) a fluorescent dye that binds specifically 
to DNA, staining was performed for confocal microscopy imaging. Briefly, 2x104 
SKOV3 cells were grown in 2 mL of fresh medium in to a glass bottom microwell 
dishes until 70-80% confluence. Cells were briefly rinsed with 2 mL PBS. For 
fixation, cells were incubated with 500 µl of cold methanol at -20°C for 10 minutes. 
After washing with 2 mL of PBS, cells were stained by adding one to two drops (150 
µl) of Vectashield Mounting Medium with DAPI stain (VECTOR Laboratories, 
USA). Cells were examined under confocal LSM 710 microscopy (Carl Zeiss, USA).  
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3.3.8 ELIMINATION OF MYCOPLASMA 
BM- Cyclin (Roche, Germany), were used to eliminate mycoplasma 
contamination following manufacturer's protocol. Treatment with BM-cyclin 
included three cycles of antibiotic curse: BM-cyclin I (pleuromutilin derivative 
antibiotic) for 3 days followed by BM-cyclin II (tetracycline derivative antibiotic) for 
4 days. To evaluate the efficiency of BM-Cyclin treatment, Lookout mycoplasma 
PCR detection kit was used. 
 
3.3.9 RNA ISOLATION  
Total RNA was extracted from 2x104 SKOV3 cells with TRIZOL reagent 
(Thermo Fisher, USA). Briefly, cells were collected and washed twice with 1 mL of 
phosphate-buffered saline (PBS) (GIBCO®, USA) and distilled water. Cells were 
then lysed by vortexing with glass disruptor beads (Electron Microscopy Sciences, 
USA). For cell homogenization, 500 µl of Trizol was added, vortexed for 3 minutes 
and incubated at room temperature for 5 minutes. Following incubation, 140 µl of 
chloroform (AMRESCO, USA) was mixed and centrifuged for 15 minutes at 
12000xg. After centrifugation, the aqueous top layer was transferred to new 
eppendorf tube and 250 µl of 100% isopropanol was added to precipitate RNA. RNA 
pellet was washed with 250 µl of 70% ethanol, and eluted with 50 µl of RNase free 
water. To determine RNA concentration and quality, Bioanalyze Agilent RNA 6000 
Nano Kit (Agilent, USA) was used.  
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3.3.10 RNA-SEQ LIBRARY CONSTRUCTION 
Following RNA isolation, 100 ng of total RNA was used to generate the RNA-
seq libraries using NEXTflex Rapid RNA-Seq Kit (Bioo Scientific, USA) according 
to the manufacturer’s instructions. Briefly, RNA was fragmented using a cationic 
buffer. Fragmented RNA undergoes first and second strand synthesis, followed by 
end-repair, adenylation, adapter ligation (NEXTflex™ RNA-Seq Barcodes) and PCR 
purification.  Amplified DNA library was purified with Agencourt AMPure XP Bead 
(Beckman Coulter Genomics, USA). The final libraries were quantified using Agilent 
Bioanalyzer 1000 DNA assay (Agilent, USA) and 8 libraries per pool were pooled.   
 
3.3.11 NEXT-GENERATION SEQUENCING (NGS) 
Paired-end 150 bp sequencing was carried out on HiSeq 400 (Illumina. USA), 
according to the manufacturer’s instructions. Clustering and amplification of 
constructed RNA-Seq libraries were conducted on cBot (illumine, USA) for 4 hours. 
The beaded flow cell was then loaded into the HiSeq 4000 and sequenced using 
HiSeq 3000/4000 SBS Kit 300 cycles (illumine, USA). Sequencing took around 72 
hours. 
 
3.3.12 DATA ANALYSIS 
Collected raw data from HiSeq 4000 were analyzed using PartekFlow (Partek, 
USA) following the workflow demonstrated in figure 3.2.  
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Figure 3.2. PartekFlow workflow for RNA-Seq analysis, showing multiple steps of 
quality checking, sequence trimming, alignment, gene analysis filtrations and heat-
map clustering. 
 
 
Samples were first assigned to three groups: control, contaminated and treated. 
Fastq files were checked for reads quality and then aligned to human reference (hg19) 
and mycoplasma reference using Bowtie2 aligner. To estimate transcript abundance 
of each condition, Partek’s “optimization of the expectation-maximization algorithm” 
was used. Differentially expressed genes were detected using gene specific analysis 
(GSA) and filtered with the followings cutoffs: P-value  = 0.01, fold-change = <-2, 
>2) and fouls discovery rate FDR = 0.01. Generated differentially expressed genes 
lists were imported to Ingenuity pathway analysis (IPA) (QIAGEN, UAS) for 
pathway analysis.  
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CHAPTER 4. RESULTS 
4.1 Survey of the incidence of mycoplasma contamination in research 
laboratories in Qatar 
Figures 4.1-8 showing responses from five research laboratories and 
institutes in Qatar [Anti-Doping Lab, Hamad Medical Corporation (HMC), Qatar 
Biomedical Research Institute  (QBRI), Qatar Cardiovascular Research Center  
(QCRC), Qatar Science and Technology Park  (QSTP), Qatar University  (QU) and 
Weill Cornell Medicine-Qatar (WCM-Q)]. The incidence of mycoplasma 
contamination reached to 42.9% in Qatar (Figure 4.3). The survey addresses the most 
commonly used cells on cell culture work, ESC Embryonic Stem Cell followed by 
SKOV3 human ovarian adenocarcinoma cell and HEK 293 Human Embryonic 
Kidney (Figure 4.2). It also addressing the most preferable methods used for 
mycoplasma detection (LookOut® mycoplasma PCR Detection Kit from Sigma 
followed by DAPI Staining) and elimination (BM-Cyclin from Roche followed by 
LookOut® mycoplasma Elimination Kit from Sigma) in Qatar (Figure 4.4 and 4.6).  
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Figure 4.1. Most common fields of cell-culture work at Qatar, other: (Cell cycle, Cell signaling, 
Quality Control, Bacteriology, Plant tissue culture, Tissue engineering, and Calcium signaling) 
 
 
 
Figure 4.2. Most commonly used cell lines at Qatar, others: (Human pancreatic cell lines, (CHO) 
Chinese hamster ovary cells, breast cancer cell lines, HUVEC, adipocyte, Hela, CML, mesenchymal 
stem cells, S2B2). 
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Figure 4.3. Frequency of mycoplsma contamination at Qatar 
 
 
 
Figure 4.4. Most commonly used mycoplasma detection methods at Qatar, others: 
(custom made primers and appearance) 
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Figure 4.5. The frequency of testing for mycoplasma contamination at Qatar, other: 
(before having an important experiment, When needed, Randomly, Every 3 months, 
daily, Only if we suspect) 
 
 
 
 
 
 
Figure 4.6. Most commonly used mycoplasma elimination methods in Qatar, others: 
(Discard contaminated cells and start new culture, antibiotics) 
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Figure 4.7. Number of passages allowed after treating cells with anti-mycoplasma in 
Qatar, others: (Once the BM cyclin treatment is done, 6 passages) 
 
 
 
Figure 4.8. Frequency of using cell culture work for gene-expression studies 
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4.2 Mycoplasma contamination test using PCR method 
Mycoplasma detection by PCR assay was used for three purposes: to 
confirm the absence of mycoplasma on control cells, to confirm the existence of 
mycoplasma on contaminated source (supernatant) and to examine mycoplasma 
contamination before sub-culturing. Agarose gel showed either single (250 bp) or two 
bands (250 bp and 500 bp) in positive control and positive sample, however, in 
negative control only single band appears at 500 bp.  
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Figure 4.9. Gel electrophoresis of PCR product of mycoplasma PCR detection test. PCR loaded 
into 2.2% agarose cassette. A) control samples after 3 and 5 days of sub-culturing. B) contaminated 
supernatant. C, D) contaminated cells at 2 to 5 passages. E) passages 2 and 4 of antibiotic treated cells. 
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4.3 Effect of mycoplasma contamination on cell morphology 
Figure 4.10. A & B shows the normal morphology (epithelial cell) of 
SKOV3 cells with normal distribution at the second passage. Contaminated SKOV3 
cells with mycoplasma were still preserving both normal cell morphology and cell 
counts after the third passages. Figure 4.10.C, at the eighth subcultures, the effect of 
mycoplasma was showing as cells aggregation and irregular distribution Figure 
4.10.D.   
 
 
 
Figure 4.10. Effect of mycoplasma contamination on cell morphology. A, B) Microscopic image of 
the second subculture of control SKOV3 cells. C, D) Microscopic image of the third and eighth 
subculture of Contaminated SKOV3 cells with Mycoplasma. Red circle is pointing to cell aggregation. 
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4.4 Mycoplasma contamination test using DAPI staining 
Figure 4.11 showing confocal microscopic imaging of control and 
mycoplasma contaminated SKOV3 cells after staining with DAPI stain. 
Contaminated cells were showing absences of mycoplasma in passage 2 to 8. 
 
 
 
 
 
Figure 4.11. Confocal microscopic imaging of control and mycoplasma contaminated SKOV3 
cells after staining with DAPI stain. A, B) Passage 3 of Mycoplasma contaminated SKOV3 cells. C, 
D) Passage 8 of Mycoplasma contaminated SKOV3 cells. 
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4.5 Effect of mycoplasma on gene-expression profile of control SKOV3 cells and 
the associated pathway analysis 
Figure 4.12 A & B showing differentially expressed genes of contaminated 
SKOV3 cells in comparison to control cells and the top enriched biological networks 
that were affected by mycoplasma.  In early passages of mycoplasma contamination, 
a total of 119 genes were significantly dis-regulated (94 genes down-regulated and 25 
genes up-regulated). While in late passages of mycoplasma contamination, the 
number of significantly dis-regulated genes was increased to 924 genes (745 genes 
down-regulated and 179 genes up-regulated). All differentially expressed genes are 
clustered based on significant genes with a cutoff = P-value with FDR  < 0.01 and 
Fold change > 2 < -2. Affected biological pathways of both early and late passages of 
contaminated cells were almost similar but with different enrichment scores. The 
most affected pathways are related to cell death and survival, cell to cell signaling, 
cell movements and immune cell trafficking (Figure 4.12 C & D). 
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Figure 4.12. A) Gene-expression heat-map of contaminated SKOV3 cells vs. Control cells in early 
passages and B) late passages of contamination, (green = down regulated, red  = up regulated) C) top 
enriched biological pathway affected by mycoplasma in early passages and D) late passages of 
contamination.  
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4.6 Effect of antibiotic treatment on gene-expression profile of contaminated 
SKOV3 cells and the associated pathway analysis 
Before proceeding with gen-expression analysis of treated cells, cell 
morphology and mycoplasma PCR test where checked. After treatment, mycoplasma 
contamination was successfully removed and SKOV3 cells were representing normal 
epithelial morphology as shown on Figure 4.13 A & B. Figure 4.14-A & B showing 
differentially expressed genes in contaminated SKOV3 cells after antibiotic treatment 
in comparison to contaminated cells.  In early passages of antibiotic treatment a total 
of 1586 genes were significantly dis-regulated (1559 genes down-regulated and 27 
up-regulated). While in late passages of antibiotic treatment, the number of dis-
regulated was deceased to 146 genes (100 genes down-regulated and 46 up-
regulated). All differentially expressed genes are clustered based on significant genes 
with a cutoff = P-value with FDR  < 0.01 and Fold change > 2 < -2.  
 
 
 
 
Figure 4.13. Effect of antibiotic treatment on SKOV3 cell morphology. A) SKOV3 cell after antibiotic 
treatment showing normal epithelial cell morphology after 8 passages. B) Gel electrophoresis of PCR product of 
mycoplasma PCR detection test of SKOV3 cells after antibiotic treatment, showing negative results. PCR loaded 
into 2.2% agarose cassette 
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Figure 4.14. A) Gene-expression heat-map of antibiotic treated SKOV3 cells vs. mycoplasma contaminated cells in 
early passages and B) late passages (green = down regulated, red  = up regulated), C) top enriched biological pathway 
affected by antibiotic treatment in early passages and D) late passages of treatment. 
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4.7 Examine the continuation effect of mycoplasma on SKOV3 cells 
To examine the continuation effect of mycoplasma on SKOV3 cells, 
differentially expressed genes of treated SKOV3 cells vs. control cells were identified 
first. In early passages of antibiotic treatment a total of 1586 genes were significantly 
dis-regulated (1225 genes down-regulated and 4 up-regulated). While in late passages 
of antibiotic treatment, a total of 793 genes were significantly dis-regulated (776 
genes down-regulated and 17 up-regulated). All differentially expressed genes are 
clustered based on significant genes with a cutoff = P-value with FDR  < 0.01 and 
Fold change > 2 < -2 (Figure. 4.15-A & B). 
Then, list of affected genes before antibiotic treatment were overlapped with 
list of genes after antibiotic treatment. Overlapping of early passages showed that 66 
genes (55 %) of differentially expressed genes in contaminated SKOV3 cells were 
disappeared after antibiotic treatment. While in late passages, 74 genes (62%) were 
disappeared after antibiotic treatment (Figure. 4.15-E & F).  
Pathway analysis of affected genes by antibiotic treatment showed enrichment 
on carbohydrate metabolism pathway with enrichment score of 24. Dis-regulation of 
this pathway will effect the ATP production in fermentative mycoplasma by 
disrupting glycolytic pathway as discussed earlier. 
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Figure 4.15. A) Gene-expression heat-map of treated SKOV3 cells vs. control cells in early passages and B) late passages 
(green = down regulated, red  = up regulated), C) top enriched biological pathway affected by antibiotic treatment in 
comparison to control cells in early passages and D) late passages, E) overlapping of differentially expressed genes of 
contaminated vs. control SKOV3 cells and treated vs. control SKOV3 cells in early passages and F) in late passages.  
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4.8 Validation of antibiotic treatment affects on control SKOV3 cells 
In order to validate that antibiotics cause the increasing number of dis-
regulated genes after treatment, control SKOV3 cells were treated with antibiotics 
directly without any previous contamination. Figure 4.16-A showing differentially 
expressed genes in treated SKOV3 cells with no previous contamination in 
comparison to control cells. Around 201 genes were significantly dis-regulated (94 
genes down-regulated and 152 up-regulated). All genes are clustered based on 
significant genes with a cutoff = P-value with FDR  < 0.01 and Fold change > 2 < -2 
and their top enriched biological pathway analysis. 
 
 
 
 
Figure 4.16. A) Gene-expression heat-map of treated SKOV3 cells with NO contamination vs. control 
cells, (green = down regulated, red = up regulated). B) Top enriched biological pathway that affected 
by antibiotic treatment 
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CHAPTER 5. DISCUSSION AND FUTURE DIRECTIONS 
1.5 DISCUSSION 
Cell-culture has become the most common biological model used in 
biology and medical research (Zalai et al., 2015). The use of cell-culture will continue 
to expand in the future due to restricted human and animals laws and protocols. 
Therefore, to insure the validity and significance of cell-culture experiments, it is 
necessary to control the right environment of cell-culture work and prevent any 
artificial changes, like unadjusted chemicals or nutrients and most importantly to 
prevent cell contamination.  
Mycoplasma contamination considered one of the serious problems in cell-
culture (Laleh et al., 2011). The effect of mycoplasma contamination in cell-culture is 
well reported and studied. These effects can range from visible effects, like cells 
physiology and metabolism alteration or invisible effects, like gene-expression 
alteration, which is more dangerous (McGarity et al., 1984 & 1985; Drexler et al., 
2000 & 2002). To date, several methods have been developed for mycoplasma 
detection and elimination in cell-culture (Schmidt et al., 1984).  
Antibiotics treatment of contaminated-cells showed the ability to eliminate 
the visible effect of mycoplasma contamination. In this study, besides identifying the 
effect of mycoplasma in gene-expression profile, we also evaluated the ability of 
antibiotics treatment in reversing these changes (invisible changes). The aim of this 
study is to answer the research question, whether mycoplasma contaminated cultured 
cells can be used or not. 
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The work of this study started with choosing suitable experimental 
variables like, cell lines, mycoplasma detection and elimination methods, number of 
cell passages and timings required. For this purpose, a survey was established, which 
investigate the incidence of mycoplasma contamination in cell-cultures and most 
frequently methods used for the detection and elimination of mycoplasma in research 
laboratories in Qatar. Based on the survey, the variables on table 5.1 were selected. 
 
 
Table 5.1. Selected variables for cell-culture work 
Cell Line: SKOV3 cells 
Mycoplasma detection method: LookOut® Mycoplasma PCR Detection 
Kit from Sigma and DAPI Staining 
Mycoplasma elimination method: BM-Cyclin from Roche  
Number of passages before using 
Antibiotic treated-cells: 
4 passages 
 
 
SKOV3 cell line was selected for this study although it was highlighted as 
the second most common used cell line after Embryonic Stem Cells (ESC) in Qatar. 
However, ESC needed a special precautions and treatments and were not available at 
the time of this study. Previous studies showed that PCR based assays are the most 
sensitive methods for mycoplasma detection (Drexler et al., 2002). In the present 
study LookOut® Mycoplasma PCR Detection Kit was the most common method to 
be used for mycoplasma detection in Qatar. The PCR based detection method was 
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able to detect mycoplasma contamination from the first passage of contaminated 
cells. Furthermore, the DAPI staining had shown lower sensitivity (Nikfarjam & 
Farzaneh 2012). In this study DAPI staining failed to detect mycoplasma 
contamination even after eight passages (56 days) of contamination. Nevertheless, we 
found that 35.7% of laboratories in Qatar using DAPI staining as the main method for 
mycoplasma detection. Along with regular microscopic examination, DAPI staining 
could also be used as a method to detect cell morphological changes caused by 
mycoplasma contamination. However, these changes are very slow and only can be 
detected at late stages of contamination. Similarly, we also found that cell 
morphological changes and cell aggregation presented after eight passages of 
contamination. 
The effectives of BM Cyclin kit (includes Tiamulin and Minocycline 
antibiotics) in curing mycoplasma contamination were evident from the first round of 
treatment in this study. This result was expected since several comparative studies 
reported that BM Cyclin kit is the most effective method for mycoplasma elimination 
(Uphoff et al., 2005).  
Our data survey on incidence of mycoplasma contamination in Qatar 
laboratories shows higher (42.9%) rates compared to the rest of the world (35%). 
Additionally, the survey also revealed that more than half of the research institutes in 
Qatar (57.1%) are using gene-expression analysis as a downstream application of 
their cell-culture work. Indeed, to prevent mycoplasma contamination, these high 
percentages should raise more considerations and precautions that should be followed 
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when dealing with cell-culture experiments in Qatar. Our findings suggest that routine 
mycoplasma testing of cultured cells should be performed in research laboratories in 
Qatar. The majority (28%) of research laboratories in Qatar do not regular testing 
their cell culture for mycoplasma contamination.  
The experimental design of this study aimed to mimic the real situation of 
mycoplasma contamination in cell-culture work. Which mostly occurs from cross 
contamination with other contaminated-cells or medium that could be represented on 
contaminated consumables like tips or splashed drops on the cell-culture cabinets 
(Hay et al., 1989). In the present study, 10 µl of contaminated media (supernatant) 
from previously contaminated SKOV3 cells were used to contaminate our SKOV3 
cell, despite the kind of mycoplasma species included on the supernatant. Supernatant 
of the same type of cell line were used to rule out the effect of any cell secretion (e.g. 
proteins, growth factors or cytokines) that differs form cell to cell type (Dowling & 
Clynes, 2011).  
The RNA-Seq analysis showed that mycoplasma dis-regulate gene-
expression profile of SKOV3 cells, which are in agreement with reports (Miller et al., 
2003; Zhang et al., 2006; Hopfe et al., 2013). We identified 119 dis-regulated genes 
in early passages, while in late passages 924 genes were dis-regulated and highly 
significant (P-value with FDR  < 0.01 and Fold change > 2 < -2). In addition, > 70% 
of these dis-regulated genes were down regulated. Pathway analysis of dis-regulated 
genes highlighted cell death and survival, cell-to-cell signaling and interaction and 
cell movement as top enriched biological pathways. Dis-regulation of these pathways 
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could explain the aggregation of contaminated-cells (Figure 4.10-D). Despite the high 
number of dis-regulated genes, we observed a slight un-noticeable changes on cell 
morphology represented as cell aggregation. 
Antibiotic treatment of contaminated cells, was able to eliminate the 
contamination, as stated above, however, genes dis-regulation were irreversible. More 
interestingly, antibiotic treatment showed more dis-regulation on the gene-expression 
profile. Unlike the effect of mycoplasma, antibiotic treatment showed a shrinking 
pattern on the number of dis-regulated genes. In early passages, 1586 genes were dis-
regulated, while in late passages the numbers of dis-regulated genes were shrinked to 
146 genes and >60% were down regulated. 
Our data suggests that the more passages after antibiotic treatment will give 
more reduction of antibiotic effect on the gene-expression profile. Though, further 
studies should be carried out to validate and evaluate the possibility of reversing all 
genes dis-regulation. The survey demonstrates that 32% of scientist in Qatar used the 
treated-cells only after two passages. However, based on our results, two passages are 
not enough to make sure that treated cell are ready to be used.  
Overlapping dis-regulated genes list SKOV3 cells before and after 
treatment, showed that some of dis-regulated genes (55% in early passages and 62% 
in late passages) were cured. While some genes were remain dis-regulated after 
treatment and other genes were dis-regulated uniquely after antibiotic treatment. 
These results led to the following concern, does the newly dis-regulated genes after 
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antibiotic treatment are due to the persistent effect of mycoplasma or due to the 
antibiotic effect! 
Thus, to study the effect of antibiotics on cells, we used antibiotic treated 
SKOV3 control cells without prior contamination and observed that the genes were 
dis-regulated due to the effect of antibiotic.  
Findings of this study concludes that contaminated cells with mycoplasma 
should not be further used or processed, specially for gene-expressions studies, due to 
the significant gene dis-regulation as consequence of either mycoplasma or antibiotics 
effects. Providentially, 6% of scientist in Qatar showed a habit of discording cells 
once they were contaminated. Nonetheless, these findings were obtained by studying 
one specific cell line (SKOV3). Hence, to generalize the effect of mycoplasma 
contamination and anti-mycoplasma treatment on gene-expression profile, other cell 
lines and antibiotics should be tested. 
 
5.2 FUTURE DIRECTION: 
• In order to validate and generalize the effect of mycoplasma contamination 
and anti-mycoplasma treatment on gene-expression profile, other cell lines 
and antibiotics will be tested in the future. 
• To understand the mechanism of witch mycoplasma dis-regulates gene-
expression of cultured cells, protein profile of contaminated cells will be 
studied using mass spectrometry (MS). 
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